JP2010513259A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513259A5 JP2010513259A5 JP2009540868A JP2009540868A JP2010513259A5 JP 2010513259 A5 JP2010513259 A5 JP 2010513259A5 JP 2009540868 A JP2009540868 A JP 2009540868A JP 2009540868 A JP2009540868 A JP 2009540868A JP 2010513259 A5 JP2010513259 A5 JP 2010513259A5
- Authority
- JP
- Japan
- Prior art keywords
- carbohydrate
- fat
- nutritional
- composition
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 24
- 235000016709 nutrition Nutrition 0.000 claims 18
- 235000014633 carbohydrates Nutrition 0.000 claims 14
- 150000001720 carbohydrates Chemical class 0.000 claims 14
- 239000003925 fat Substances 0.000 claims 14
- 229940024606 amino acid Drugs 0.000 claims 12
- 235000001014 amino acid Nutrition 0.000 claims 12
- 150000001413 amino acids Chemical class 0.000 claims 12
- 239000000047 product Substances 0.000 claims 10
- 238000009472 formulation Methods 0.000 claims 9
- 238000002360 preparation method Methods 0.000 claims 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 6
- 208000012202 Pervasive developmental disease Diseases 0.000 claims 6
- 208000029560 autism spectrum disease Diseases 0.000 claims 6
- 235000018102 proteins Nutrition 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 6
- 235000013325 dietary fiber Nutrition 0.000 claims 5
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 3
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 3
- 229930064664 L-arginine Natural products 0.000 claims 3
- 235000014852 L-arginine Nutrition 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 3
- 235000019393 L-cystine Nutrition 0.000 claims 3
- 239000004158 L-cystine Substances 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- 229930182844 L-isoleucine Natural products 0.000 claims 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 3
- 229930195722 L-methionine Natural products 0.000 claims 3
- 239000004473 Threonine Substances 0.000 claims 3
- 229960003767 alanine Drugs 0.000 claims 3
- 229960005261 aspartic acid Drugs 0.000 claims 3
- 229960003067 cystine Drugs 0.000 claims 3
- 229960002449 glycine Drugs 0.000 claims 3
- 229960002885 histidine Drugs 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- 229960004452 methionine Drugs 0.000 claims 3
- 239000006041 probiotic Substances 0.000 claims 3
- 230000000529 probiotic effect Effects 0.000 claims 3
- 235000018291 probiotics Nutrition 0.000 claims 3
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims 3
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 3
- 229960003080 taurine Drugs 0.000 claims 3
- 229960002898 threonine Drugs 0.000 claims 3
- 229960004441 tyrosine Drugs 0.000 claims 3
- 229960004295 valine Drugs 0.000 claims 3
- 208000036640 Asperger disease Diseases 0.000 claims 2
- 201000006062 Asperger syndrome Diseases 0.000 claims 2
- 206010003805 Autism Diseases 0.000 claims 2
- 208000020706 Autistic disease Diseases 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- 229930182816 L-glutamine Natural products 0.000 claims 2
- 208000006289 Rett Syndrome Diseases 0.000 claims 2
- 208000036353 Rett disease Diseases 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 2
- 230000037213 diet Effects 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 229960001153 serine Drugs 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- VOOGILFUHUXBEV-ZBRNBAAYSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound OC[C@H](N)C(O)=O.OC(=O)[C@@H]1CCCN1 VOOGILFUHUXBEV-ZBRNBAAYSA-N 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0624879.3A GB0624879D0 (en) | 2006-12-14 | 2006-12-14 | Treatment of pervasive development disorders |
| PCT/GB2007/004815 WO2008071991A1 (en) | 2006-12-14 | 2007-12-14 | Treatment of pervasive developmental disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010513259A JP2010513259A (ja) | 2010-04-30 |
| JP2010513259A5 true JP2010513259A5 (enExample) | 2012-03-22 |
Family
ID=37712065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540868A Pending JP2010513259A (ja) | 2006-12-14 | 2007-12-14 | 広汎性発達障害の治療 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100055073A1 (enExample) |
| EP (1) | EP2091526B1 (enExample) |
| JP (1) | JP2010513259A (enExample) |
| AT (1) | ATE507827T1 (enExample) |
| AU (1) | AU2007331276A1 (enExample) |
| BR (1) | BRPI0720230B8 (enExample) |
| CA (1) | CA2672738A1 (enExample) |
| DE (1) | DE602007014400D1 (enExample) |
| ES (1) | ES2365469T3 (enExample) |
| GB (1) | GB0624879D0 (enExample) |
| IL (1) | IL199340A0 (enExample) |
| MX (1) | MX2009006459A (enExample) |
| PL (1) | PL2091526T3 (enExample) |
| RU (1) | RU2441652C2 (enExample) |
| WO (1) | WO2008071991A1 (enExample) |
| ZA (1) | ZA200904240B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010137944A1 (en) * | 2009-05-27 | 2010-12-02 | N.V. Nutricia | Treatment of hypercalcaemia |
| MX2013003636A (es) | 2013-03-27 | 2014-09-29 | Palsgaard Ind De Mexico S De R L De C V | Complemento alimenticio para personas con trisomia 21, transtorno del espectro autista y/o transtorno por deficit de atencion con o sin hiperactividad. |
| WO2015002527A1 (en) * | 2013-07-05 | 2015-01-08 | N.V. Nutricia | Amino acid composition for use in the treatment of a pdd |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| US11617731B2 (en) | 2017-04-28 | 2023-04-04 | Axcella Health, Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
| EP3630124A4 (en) * | 2017-05-24 | 2021-02-24 | Glycom A/S | Synthetic composition comprising oligosaccharides and its use in medical treatment. |
| MA49906A (fr) | 2017-08-14 | 2020-06-24 | Axcella Health Inc | Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie |
| EP3810123A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| WO2022258873A1 (es) * | 2021-06-09 | 2022-12-15 | Hospital Sant Joan De Deu | Combinación nutracéutica y su uso para el tratamiento de trastornos neurológicos |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4414238A (en) * | 1981-12-24 | 1983-11-08 | Cutter Laboratories, Inc. | Liquid elemental diet |
| US6294520B1 (en) * | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| US5719133A (en) * | 1994-09-21 | 1998-02-17 | Novartis Nutrition Ag | Adolescent dietary composition |
| SE510813C2 (sv) * | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen |
| WO2002043507A2 (en) * | 2000-11-30 | 2002-06-06 | The Health Research Institute | Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| CN1255413C (zh) * | 2001-06-14 | 2006-05-10 | 阿克佐诺贝尔公司 | 作为ampa受体正性调节剂的(吡啶并/噻吩并)-[f]-氧杂吖庚因-5-酮衍生物 |
| US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
-
2006
- 2006-12-14 GB GBGB0624879.3A patent/GB0624879D0/en not_active Ceased
-
2007
- 2007-12-14 EP EP07858785A patent/EP2091526B1/en active Active
- 2007-12-14 PL PL07858785T patent/PL2091526T3/pl unknown
- 2007-12-14 MX MX2009006459A patent/MX2009006459A/es active IP Right Grant
- 2007-12-14 AT AT07858785T patent/ATE507827T1/de not_active IP Right Cessation
- 2007-12-14 WO PCT/GB2007/004815 patent/WO2008071991A1/en not_active Ceased
- 2007-12-14 BR BRPI0720230A patent/BRPI0720230B8/pt not_active IP Right Cessation
- 2007-12-14 RU RU2009126763/15A patent/RU2441652C2/ru active
- 2007-12-14 ZA ZA200904240A patent/ZA200904240B/xx unknown
- 2007-12-14 AU AU2007331276A patent/AU2007331276A1/en not_active Abandoned
- 2007-12-14 JP JP2009540868A patent/JP2010513259A/ja active Pending
- 2007-12-14 DE DE602007014400T patent/DE602007014400D1/de active Active
- 2007-12-14 ES ES07858785T patent/ES2365469T3/es active Active
- 2007-12-14 CA CA002672738A patent/CA2672738A1/en not_active Abandoned
-
2009
- 2009-06-12 US US12/483,580 patent/US20100055073A1/en not_active Abandoned
- 2009-06-14 IL IL199340A patent/IL199340A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513259A5 (enExample) | ||
| ES2555257T3 (es) | Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales | |
| RU2009126763A (ru) | Лечение общих расстройств развития | |
| ES2436145T3 (es) | Método para disminuir el amargor y mejorar el sabor de leches maternizadas sin proteínas e hidrolizadas | |
| AU765986B2 (en) | Composition for an infant formula having a low threonine content | |
| JP2005501061A5 (enExample) | ||
| JP2009534323A5 (enExample) | ||
| ES2111384T3 (es) | Composicion dietetica para adolescentes. | |
| WO2008081582A1 (ja) | 容器詰飲料 | |
| RU2013151083A (ru) | ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ (α-HICA) И ЦИТРУЛЛИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2016509994A5 (enExample) | ||
| JP2011523626A5 (enExample) | ||
| JP2023507064A (ja) | タンパク質に由来するアミノ酸の生物学的利用能の上昇に使用するための菌株を含む組成物 | |
| JP5687697B2 (ja) | 体重増加の抑制及び/又は体重減少に使用するための魚類タンパク質の加水分解産物 | |
| ES2991650T3 (es) | Preparado infantil extensamente hidrolizado | |
| US20210127647A1 (en) | Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease | |
| RU2015133023A (ru) | Активация адипонектина с использованием гидролизата казеина | |
| JP2019515881A5 (enExample) | ||
| KR900013872A (ko) | 영양 조성물 | |
| BR112013033372A2 (pt) | suplemento nutritivo, método para aumentar a massa bacteriana no rúmen de um ruminante, e preparado nutritivo e usos correspondentes | |
| WO2018050708A1 (en) | Spoonable nutritional composition | |
| JPH04159219A (ja) | 腎不全用経口アミノ酸製剤 | |
| JP2005289938A5 (enExample) | ||
| Chung et al. | Effects of Proteolytic Activity of Multi-Species Probiotics on Dietary Protein Absorption and Muscle Physiology | |
| Franzói De Moraes et al. | Creatine supplementation in trained rats causes changes in myenteric neurons and intestinal wall morphometry |